pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS
BEONE MEDICINES AUS PTY LTD
BEONE MEDICINES AUS is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Solid Tumor, Adult, Mantle Cell Lymphoma, Previous
Cambridge, USA HQ
2010 Founded
3,177 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 3,177
- Programs
- 122
- Drugs
- 63
- Patents
- 0
Blinatumomab
Phase 2 · small molecule · B Cell Precursor Acute Lymphoblastic Leukemia
Blinatumomab for B Cell Precursor Acute Lymphoblastic Leukemia is a Phase 2 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).
Internal code 20180257
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- BEONE MEDICINES AUS PTY LTD
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- B Cell Precursor Acute Lymphoblastic Leukemia
- Status
- active
- Trials
- 1